Home > Quotes > NAVB

Navidea Biopharmaceuticals, Inc. Common Stock Quote & Summary Data

NAVB 
$1.34
*  
0.03
2.19%
Get NAVB Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading NAVB now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Navidea Biopharmaceuticals, Inc. Common Stock Intraday Chart




News for NAVB

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 1.38 $ 2.495
Low $ 1.34 $ 0.75

The current last sale of $1.34 is 78.67% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Navidea Biopharmaceuticals, Inc. (Navidea, the Company, or we), a Delaware corporation (NYSE MKT: NAVB), is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on our Manocept(TM) platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Navidea's Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Lymphoseek® (technetium Tc 99m tilmanocept) injection, the first product developed by Navidea based on the platform.  ... More ...  

Risk Grade

Where does NAVB fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?